<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="and provoked a still ongoing and dangerous pandemic known as" exact="coronavirus disease 2019" post="(COVID-19). The SARS-CoV-2 infection has triggered an impressive amount"/>
 <result pre="and dangerous pandemic known as coronavirus disease 2019 (COVID-19). The" exact="SARS-CoV-2 infection" post="has triggered an impressive amount of clinical and experimental"/>
 <result pre="access and use convalescent plasma for the treatment of life-threatening" exact="SARS-CoV-2 infection." post="However, there is still, limited data on the sero-conversion"/>
 <result pre="there is still, limited data on the sero-conversion following the" exact="SARS-CoV-2 infection" post="as well as on its associated side effects, such"/>
 <result pre="the most certain solution to ensure a direct protection against" exact="SARS-CoV-2 infection." post="The development of vaccines for human use represents a"/>
 <result pre="use of remdesivir on a compassionate-use basis to patients with" exact="SARS-CoV-2 infection" post="receiving oxygen support, has been associated with a clinical"/>
 <result pre="(Goraya et al., 2020) but has been less documented in" exact="SARS-CoV-2 infection." post="Recently, Ziegler et al. proved that ACE2 SARS-CoV-2 receptor"/>
 <result pre="Cochrane database. Table 1 Interferon therapy in clinical evaluation in" exact="SARS-CoV-2 infection" post="(July 20, 2020). Biological treatment Study identifier number, locations"/>
 <result pre="the non-specific vaccine which has received most attention in the" exact="SARS-CoV-2 infection" post="due to its ability to boost the immunity against"/>
 <result pre="a stepping stone for the handling of future epidemics. The" exact="SARS-CoV-2 infection" post="proved once again that viruses leave a very short"/>
 <result pre="K.ZingmanB. S.KalilA. C.et al. (2020). Remdesivir for the Treatment of" exact="Covid-19" post="â€&quot; Preliminary Report. N. Engl. J. Med.4 (2), 93â€&quot;107."/>
 <result pre="al. (2019). IFN-I response timing relative to virus replication determines" exact="MERS coronavirus" post="infection outcomes. J. Clin. Invest.129 (9), 3625â€&quot;3639. 10.1172/JCI12636331355779 ChenX.ZhaoB.QuY.ChenY.XiongJ.FengY.et"/>
 <result pre="BALB/c mice: CD4+ T cells are important in control of" exact="SARS-CoV infection." post="J. Virol.84 (3), 1289â€&quot;1301. 10.1128/JVI.01281-0919906920 ContiP.RonconiG.CaraffaA.GallengaC.RossR.FrydasI.et al. (2020). Induction"/>
 <result pre="considerations with chloroquine, hydroxychloroquine and azithromycin in the management of" exact="SARS-CoV-2 infection." post="CMAJ192 (17), E4540â€&quot;E453. 10.1503/cmaj.200528 KawaseM.ShiratoK.van der HoekL.TaguchiF.MatsuyamaS. (2012). Simultaneous"/>
 <result pre="severe acute lung injury by skewing macrophage responses during acute" exact="SARS-CoV infection." post="JCI Insight4 (4), e123158. 10.1172/jci.insight.123158 MacchiagodenaM.PagliaiM.ProcacciP. (2020). Inhibition of"/>
 <result pre="Â 10.1056/NEJMoa200897532356628 RichardsonP.GriffinI.TuckerC.SmithD.OechsleO.PhelanA.et al. (2020). Baricitinib as potential treatment for" exact="2019-nCoV acute respiratory disease." post="Lancet (London England)395 (10223), e30â€&quot;e31. 10.1016/S0140-6736(20)30304-4 RogersT. F.ZhaoF.HuangD.BeutlerN.BurnsA.HeW.et al."/>
 <result pre="D. M. E.et al. (2020). A human monoclonal antibody blocking" exact="SARS-CoV-2 infection." post="Nat. Commun.11 (1), 2251. 10.1038/s41467-020-16256-y32366817 WangM.CaoR.ZhangL.YangX.LiuJ.XuM.et al. (2020). Remdesivir"/>
 <result pre="ChenX. T. (2020). Guidelines for the diagnosis and treatment of" exact="coronavirus disease 2019" post="(COVID-19) in China. Glob. Heal. Med.2 (2), 66â€&quot;72. 10.35772/ghm.2020.01015"/>
</results>
